Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12117453 Predicting patient response to sodium channel blockers

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
December 9, 2019
0
Date of Patent
October 15, 2024
0
Patent Application Number
16708312
0
Patent Citations
‌
US Patent 7846968 Methods for QT interval control
0
‌
US Patent 8173840 Compounds with high therapeutic index
0
‌
US Patent 8563776 L-Threonine derivatives of high therapeutic index
0
‌
US Patent 8660651 Electrical stimulation method for treatment of peripheral neuropathy
0
‌
US Patent 9044482 Use of aminoindane compounds in treating overactive bladder and interstitial cystitis
0
‌
US Patent 9597302 Combination of dofetilide and mexiletine for the prevention and treatment of atrial fibrillation
0
‌
US Patent 9375423 Use of aminoindane compounds in treating overactive bladder and interstitial cystitis
0
‌
US Patent 10004744 Therapeutic approaches for treating Parkinson's disease
0
‌
US Patent 7094600 Screen for sodium channel modulators
0
‌
US Patent 7674820 Ion channel modulating activity I
0
Patent Inventor Names
Andrea Mazzanti
0
Wandi Zhu
0
Kristen Naegle
0
Jonathan Silva
0
Silvia Priori
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12117453
0
Patent Primary Examiner
‌
G Steven Vanni
0

Find more entities like US Patent 12117453 Predicting patient response to sodium channel blockers

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo